EMBO Journal 1997-12-01

The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen.

I García-Sáez, D Reverter, J Vendrell, F X Avilés, M Coll

文献索引:EMBO J. 16(23) , 6906-13, (1997)

全文:HTML全文

摘要

The three-dimensional structure of human procarboxypeptidase A2 has been determined using X-ray crystallography at 1.8 A resolution. This is the first detailed structural report of a human pancreatic carboxypeptidase and of its zymogen. Human procarboxypeptidase A2 is formed by a pro-segment of 96 residues, which inhibits the enzyme, and a carboxypeptidase moiety of 305 residues. The pro-enzyme maintains the general fold when compared with other non-human counterparts. The globular part of the pro-segment docks into the enzyme moiety and shields the S2-S4 substrate binding sites, promoting inhibition. Interestingly, important differences are found in the pro-segment which allow the identification of the structural determinants of the diverse activation behaviours of procarboxypeptidases A1, B and A2, particularly of the latter. The benzylsuccinic inhibitor is able to diffuse into the active site of procarboxypeptidase A2 in the crystals. The structure of the zymogen-inhibitor complex has been solved at 2.2 A resolution. The inhibitor enters the active site through a channel formed at the interface between the pro-segment and the enzyme regions and interacts with important elements of the active site. The derived structural features explain the intrinsic activity of A1/A2 pro-enzymes for small substrates.


相关化合物

  • DL-苄基丁二酸

相关文献:

Regulation of cytoplasmic tubulin carboxypeptidase activity in vitro by cations and sulfhydryl-modifying compounds.

1996-03-01

[J. Cell. Biochem. 60(3) , 424-36, (1996)]

Nerve injury evoked loss of latexin expression in spinal cord neurons contributes to the development of neuropathic pain.

2011-01-01

[PLoS ONE 6(4) , e19270, (2011)]

Bacterial chemotactic oligopeptides and the intestinal mucosal barrier.

1989-07-01

[Gastroenterology 97(1) , 61-7, (1989)]

[Design, synthesis and hypoglycemic activity of alpha-benzylsuccinic acid derivatives].

2009-05-01

[Yao Xue Xue Bao 44(5) , 491-5, (2009)]

History of heart failure.

2009-01-01

[Congest. Heart Fail. 15(1) , 49, (2009)]

更多文献...